Abstract
The administration of neurotensin into the ventral tegmental area stimulates dopamine neurons and locomotor activity. Furthermore, when neurotensin is microinjected daily into the ventral tegmental area the motor stimulant response increases. The role of protein kinases in the motor stimulant effect of neurotensin was evaluated by coadministration of the protein kinase inhibitors H8 and H7 into the ventral tegmental area with neurotensin. It was found that the acute motor stimulant effect of neurotensin was abolished in a dose-dependent fashion by H8 coadministration. Neurotensin-induced activity was also blocked by H7. However, acute motor stimulation following microinjection of the mu opioid, Tyr-d-Ala-Gly-MePhe-Gly(ol) or the potassium channel antagonist apamin into the ventral tegmental area was not affected by coadministration with H8. The behavioral sensitization produced by daily neurotensin microinjection into the ventral tegmental area was also prevented by the coadministration of H8. These data indicate that the motor stimulation produced by acute and repeated neurotensin microinjection into the ventral tegmental area is dependent upon activation of protein kinase(s). Furthermore, Tyr-d-Ala-Gly-MePhe-Gly(ol) and apamine elicit locomotion independently of protein kinase(s).
Similar content being viewed by others
References
Agnati LF, Fuxe K, Benfenati F, Battistinni N (1983) Neurotensin in vitro markedly reduces the affinity in subcortical limbic3H-N-propylapomorphine binding sites. Acta Physiol Scand 119:459–461
Akers RF, Lovinger DM, Colley PA, Linden DJ, Routtenberg A (1986) Translocation of protein kinase C activity may mediate hippocampal long-term potentiation. Science 231:587–589
Alkon DL, Nelson TJ (1990) Specificity of molecular changes in neurons involved in memory storage. FASEB J 4:1567–1576
Allende JE (1988) GTP-mediated macromolecular interactions: the common features of different systems. FASEB J 2:2356–2367
Cador M, Kelley AE, LeMoal M, Stinus L (1985) Behavioral analysis of the effect of neurotensin injected into the ventral mesencephalon on investigatory and spontaneous motor behavior in the rat. Psychopharmacology 85:37–46
Cador M, Rivet JM, Kelley A, Le Moal M, Stinus L (1989) Substance P, neurotensin and enkephalin injections into the ventral tegmental area: comparative study on dopamine turnover in several forebrain structures. Brain Res 489:357–363
Castle NA, Haylett DG, Jenkinson DH (1989) Toxins in the characterization of potassium channels. Trends Neurosci 12:59–65
Cunningham T, Kelley AE (1993) Hyperactivity and sensitization to psychostimulants following infusion of choleratoxin into the nucleus accumbens. J Neurosci 13:2342–2350
Dana C, Vial M, Leonard K, Beauregard A, Kitabgi P, Vincent J-P, Rostene W, Beaudet A (1989) Electron microscopic localization of neurotensin binding sites in the midbrain tegmentum of the rat. I. Ventral tegmental area and interfascicular nucleus. J Neurosci 9:2247–2257
Dilts R, Kalivas PW (1989) Autoradiographic localization of mu opioid and neurotensin receptors within the mesolimbic dopamine system. Brain Res 488:311–328
Elazar Z, Fuchs S (1991) Phosphorylation by cyclic AMP-dependent protein kinase modulates agonist binding to the D2 dopamine receptor. J Neurochem 56:75–80
Elliot PJ, Nemeroff CB (1986) Repeated neurotensin administration in the ventral tegmental area: effects on baseline andd-amphetamine-induced locomotor activity. Neurosci Lett 68:239–244
Faggin BM, Zubieta JK, Rezvani AH, Cubeddu LX (1990) Neurotensin-induced dopamine release in vivo and in vitro from substantia nigra and nucleus caudate. J Pharmacol Exp Ther 252:817–825
Fuxe K, Agnati LF, Anderson K, Eneroth P, Harfstrand A, Goldstein M, Zoli M (1984) Studies on neurotensin-catecholamine interactions in the hypothalamus and in the forebrain of the male rat. Neurochem Int 6:737–750
Gysling K, Wang RY (1983) Morphine-induced activation of A10 dopamine neurons in the rat brain. Brain Res 277:119–127
Hokfelt T, Everitt BJ, Theodorsson-Norheim E, Goldstein M (1984) Occurrence of neurotensin-like immunoreactivity in subpopulations of hypothalamic, mesencephalic, and medullary catecholamine neurons. J Comp Neurol 222:543–559
Hugues M, Romey G, Duval D, Vincent JP, Lazdunski M (1982) Apamin as a selective blocker of the calcium-dependent potassium channel in neuroblastoma cells: voltage-clamp and biochemical characterization of the toxin receptor. Proc Natl Acad Sci USA 79:1308–1312
Innis RB, Andrade R, Aghajanian GK (1985) Substance K excites dopaminergic and nondopaminergic neurons in rat substantia nigra. Brain Res 335:381–383
Jennes L, Stumpf W, Kalivas PW (1982) Neurotensin: topographical distribution in rat brain by immunohistochemistry. J Comp Neurol 210:213–224
Johnson SW, North RA (1992) Opioids excite dopamine neurons by hyperpolarization of local interneurons. J Neurosci 12:483–488
Kalivas PW, Duffy P (1990) Effect of acute and daily neurotensin and enkephalin treatments on extracellular dopamine in the nucleus accumbens. J Neurosci 10:2940–2949
Kalivas PW, Steketee J (1992) Possible transduction mechanisms mediating the acute and sensitized response to neurotensin in the ventral tegmental area. Ann NY Acad Sci 668:157–164
Kalivas PW, Stewart J (1991) Dopamine transmission in the initiation and expression of drug- and stress-induced sensitization of motor activity. Brain Res Rev 16:223–244
Kalivas PW, Taylor S (1985) Effect of daily neurotensin injection into the ventral tegmental area. Brain Res 358:70–76
Kalivas PW, Burgess SK, Nemeroff CB, Prange AJJr (1983) Behavioral and neurochemical effects of neurotensin microinjection into the ventral tegmental area. Neuroscience 8:496–505
Kalivas PW, Duffy P, Eberhardt H (1990) Modulation of A10 dopamine neurons by GABA agonists. J Pharmacol Exp Ther 253:858–866
Kato S, Ishita S, Mawatari K, Matsukawa T, Negishi K (1990) Dopamine release via protein kinase C activation in the fish retina. J Neurochem 54:2082–2090
Kelley AE, Stinus L, Iversen SD (1980) Interactions betweend-Ala-Metenkephalin, A10 dopaminergic neurons, and spontaneous behavior in the rat. Behav Brain Res 1:3–24
Klitenick MA, De Witte P, Kalivas PW (1992) Regulation of dopamine and GABA release in the ventral tegmental area by opioids and GABA. J Neurosci 12:2623–2632
Lacey MG, Mercuri NB, North RA (1988) On the potassium conductance increase activated by GABAB and dopamine receptors in rat substantia nigra neurones. J Physiol (Lond) 401:437–454
Lacey MG, Mercuri NB, North RA (1989) Two cell types in rat substantia nigra zona compacta distinguished by membrane properties and the actions of dopamine and opioids. J Neurosci 9:1233–1241
Laitinen K, Crawley JN, Mefford IN, De Witte P (1990) Neurotensin and cholecystokinin microinjected into the ventral tegmental area modulate microdialysate concentration of dopamine and its metabolites in the posterior nucleus accumbens. Brain Res 523:342–346
Latimer LG, Duffy P, Kalivas PW (1987) Mu opioid receptor involvement in enkephalin activation of dopamine neurons in the ventral tegmental area. J Pharmacol Exp Ther 241:328–337
Malenka RC, Kauer JA, Perkel DJ, Mauk MD, Kelly PT, Nicoll RA, Waxham MM (1989) An essential role for postsynaptic calmodulin and protein kinase activity in long-term potentiation. Nature 340:554–557
Milliken GA, Johnson DE (1984) Analysis of messy data, vol I. Designed experiments. Lifetime Learning Publications, Belmont, Calif.
Palacios JM, Kuhar MJ (1981) Neurotensin receptors are found on dopaminergic-containing neurons in the rat brain: an autoradiographic study. Nature 294:587–589
Pellegrino LK, Pellegrino AS, Cushman AJ (1979) A stereotaxic atlas of the rat brain. Plenum Press, New York
Pinnock RD (1985) Neurotensin depolarizes substantia nigra dopamine neurons. Brain Res 338:151–154
Quirion R, Chieuh CC, Everist HD, Pert A (1985) Comparative localization of neurotensin receptors on nigrostriatal and mesolimbic dopaminergic terminals. Brain Res 327:385–389
Rivest R, Jolicoeur FB, Marsden CA (1991) Neurotensin causes a greater increase in the metabolism of dopamine in the accumbens than in the striatum in vivo. Neuropharmacology 30:25–33
Saitoh M, Ishikawa T, Matsushima S, Naka M, Hidaka H (1987) Selective inhibition of catalytic activity of smooth muscle myosin light chain kinase. J Biol Chem 262:7796–7801
Seroogy KB, Mehta A, Fallon JH (1987) Neurotensin and cholecystokinin coexistence within neurons of the ventral mesencephalon: projections to forebrain. Exp Brain Res 68:227–289
Seutin V, Massotte L, Dresse A (1989) Electrophysiological effects of neurotensin on dopaminergic neurons of the ventral tegmental area of the rat in vitro. Neuropharmacology 28:949–954
Shepard PD, Bunney BS (1988) Effects of apamin on the discharge properties of putative dopamine-containing neurons in vitro. Brain Res 463:380–384
Shi WX, Bunney BS (1991) Neurotensin modulates autoreceptor mediated dopamine effects on midbrain dopamine cell activity. Brain Res 543:315–321
Shi WX, Bunney BS (1992) Roles of intracellular cAMP and protein kinase A in actions of dopamine and neurotensin on midbrain dopamine neurons. J Neurosci 12:2433–2438
Steketee JD, Kalivas PW (1990) Modulation of dopamine neurons by apamin. J Pharmacol Exp Ther 254:711–719
Steketee JD, Striplin DC, Murray TF, Kalivas PW (1992) Effect of pertussis toxin in the A10 region on dopamine transmission. J Neurochem 58:811–816
Talmaciu RK, Hoffmann IS, Cubeddu LX (1989) Differential effects of phorbol ester on prefrontal cortex and striatal dopamine terminals: dependence on rate and duration of stimulation. J Pharmacol Exp Ther 251:1160–1165
Tanaka K, Masu M, Nakanishi S (1990) Structure and functional expression of the cloned rat neurotensin receptor. Neuron 4:847–854
Tanganelli S, Von Euler G, Fuxe K, Agnati LF, Ungerstedt U (1989) Neurotensin counteracts apomorphine-induced inhibition of dopamine release as studied by microdialysis in rat neostriatum. Brain Res 502:319–324
Uhl GR, Kuhar MJ, Snyder SH (1977) Neurotensin: immunohistochemical localization in rat central nervous system. Proc Natl Acad Sci USA 74:4059–4063
Von Euler G, Mailleux P, Vanderhaeghen J-J, Fuxe K (1990) Neurotensin reduces the affinity of dopamine D-2 receptors in membranes from post mortem human caudate-putamen. Neurosci Lett 109:325–330
Von Euler G, Van Der Ploeg I, Fredholm BB, Fuxe K (1991) Neurotensin decreases the affinity of dopamine D2 agonist binding by a G protein-independent mechanism. J Neurochem 56:178–183
Author information
Authors and Affiliations
Rights and permissions
About this article
Cite this article
Kalivas, P.W. Blockade of neurotensin-induced motor activity by inhibition of protein kinase. Psychopharmacology 114, 175–180 (1994). https://doi.org/10.1007/BF02245461
Received:
Revised:
Issue Date:
DOI: https://doi.org/10.1007/BF02245461